Orion Biotechnology Presented at the 3rd GPCR-Targeted Drug Discovery Summit in Boston

13.03.2024

Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled...

Orion Biotechnology featured on BestStock.com

29.08.2023

Lorem ipsum dolor sit amet consectetur. Ultrices pretium sollicitudin aliquam interdum sed set amet in... Lorem ipsum dolor sit amet consectetur. Ultrices pretium sollicitudin aliquam...

Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months

18.07.2023

Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled...

Orion Biotechnology Presenting at the 2nd GPCR-Targeted Drug Discovery Summit in Boston

18.02.2023

Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled...